Teaching HospitalCached Profile
UT Southwestern Medical Center
Address: 5323 Harry Hines Blvd, Dallas, TX 75390
CCN Number: 450044
LIFETIME INDUSTRY FOOTPRINT
$2,397,212
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funding Sources (Cumulative)
Corporate pharmaceutical and medical device manufacturers contributing to overall totals.
1. INTUITIVE SURGICAL$968,400 (40.4%)
2. ELEKTA$534,550 (22.3%)
3. EMD MILLIPORE CORPORATION$255,752 (10.7%)
Active & Completed Clinical Trials
Medical trials listing this teaching hospital as sponsor or collaborator.
A Pilot Study of Intravenous EZN-2285 (SC-PEG E. Coli L-asparaginase) or Intravenous Oncaspar® in the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia (ALL)
COMPLETEDPhase PHASE3NCT00671034
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer
COMPLETEDPhase PHASE3NCT03517449
OPTImal Ventilation to Improve Pediatric Cardiac Arrest Outcomes (OPTI-VENT)
RECRUITINGPhase NANCT07114510
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)
ACTIVE_NOT_RECRUITINGPhase PHASE1NCT03600883
Trifecta-Lung cfDNA-MMDx Study: Comparing the Dd-cfDNA Test to MMDx Microarray Test and Central HLA Antibody Test
RECRUITINGPhase N/ANCT05837663
Teaching Hospital General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2024
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for 450044...